At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is April 2026’s round-up.
Investments
ONTO Health raises $20M Series A for AI-enabled fertility and longevity care; announces Gulf region expansion.
Osteoboost Health raises $8M to scale its FDA-cleared wearable for bone health in postmenopausal women.
Wavelet Medical raises $7M to bring non-invasice fetal brain monitoring to labor and delivery.
Future Fertility raises $4.1M Series A to scale AI-powered egg squality assessment globally.
Men's fertility supplement brand TIES launches with $1.5M in seed funding.
Zócalo Health raises $15M in Series A funding to scale community-based care for underserved populations.
BASE4 Biosciences raises $1M pre-seed to build sex-specific biological atlas from a single blood test.
Protocole raises $6M in seed funding to build a clinical grade peptide platform.
Sub-Q raises $1.5M and signs a Mayo Clinic licensing deal to develop implantable lymphedema device.
Australian startup Proseek Bio raises A$1.5M to commericalize its ovarian cancer detection blood test.
Flora Fertility raises $5M for individually owned fertility insurance.
SimpliFed raises $10.8M Series A to expand from lactation support into virtual OB Care.
ScreenPoint Medical raises $16M to scale AI-powered breast cancer detection globally.
Canadian menopause care platform Coral adds $4M CAD.
UK virtual fertility clinic Plan Your Baby closes seed round.
Supplement brand Amulet launches with investor backing from Maria Sharapova.
Omaia closes a pre-seed round for its pregnancy emotional support platform.
Acquisitions
Sun Pharma is to acquire women's health pharma giant Organon in $11,75 Billion deal.
Funds
UK Impact VC Eka Ventures closes $107M second fund.
European biopharma investor Jeito Capital closes $1.2B fund.
Beiersdorf launches a €100M venture capital fund focused on skin care innovation.
